Boston biopharma commercializing Nationwide Children’s gene therapies to add Columbus office, 100 jobs

A Boston-area biopharmaceutical company that licensed or optioned several technologies from Nationwide Children’s Hospital plans to open a Columbus office next year with 100 scientific and regulatory employees.

Sarepta Therapeutics Inc. plans to open the first phase of its Gene Therapy Center of Excellence in spring and expand throughout 2019.

Click here to read the complete article.

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Originally published October 16, 2018.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: